SHANGHAI, April 3 (Reuters) - A drugmaker in China has developed a biosimilar version of Novo Nordisk's (NOVOb.CO) popular diabetes drug Ozempic and applied for approval to sell it there, in a ...

The West’s pharmaceutical industry is alarmingly dependent on China. From antibiotics to essential medications, China controls a massive portion of the global drug supply.

Business China shook up AI with DeepSeek. Now it’s doing the same with medicine (CNN) — China’s DeepSeek shocked the world by delivering unexpected innovation at an unbelievable price.

Ivonescimab, the new drug, was found in a trial conducted in China to have bested Keytruda, the blockbuster medication developed by Merck that has raked in more than $130 billion in sales for the ...

Novo Nordisk’s Ozempic drug—which contains the same semaglutide active ingredient as Wegovy—was approved to treat diabetes in China in 2021. Sales of the drug in the country more than ...

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, including a first-of-its-kind molecule in blood cancer. | Chinese ...

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with ...

Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market where it estimates more than 180 million people live with ...

Ivonescimab, the new drug, was found in a trial conducted in China to have bested Keytruda, the blockbuster medication developed by Merck that has raked in more than $130 billion in sales for the ...